CHRONIC ACTIVE ANTIBODY-MEDIATED REJECTION

Clinical trials for CHRONIC ACTIVE ANTIBODY-MEDIATED REJECTION explained in plain language.

Never miss a new study

Get alerted when new CHRONIC ACTIVE ANTIBODY-MEDIATED REJECTION trials appear

Sign up with your email to follow new studies for CHRONIC ACTIVE ANTIBODY-MEDIATED REJECTION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet recruiting 1 Completed 1

Stem cell therapy fails to improve kidney rejection, raises safety flags

Disease control Not yet recruiting

This study tested whether a person's own stem cells (mesenchymal stem cells) could help treat chronic active antibody-mediated rejection in kidney transplant recipients. Only 3 patients were enrolled before the study was stopped early due to serious side effects. The treatment di…

Matched conditions: CHRONIC ACTIVE ANTIBODY-MEDIATED REJECTION

Phase: NA • Sponsor: Shahid Beheshti University of Medical Sciences • Aim: Disease control

Last updated Jun 27, 2026 09:05 UTC

CHRONIC ACTIVE ANTIBODY-MEDIATED REJECTION

Get alerted when new CHRONIC ACTIVE ANTIBODY-MEDIATED REJECTION trials appear

Stem cell therapy fails to improve kidney rejection, raises safety flags